SEC EDGAR Filing Information

Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]

Filing Date Changed: 2008-02-14
Group Members: JOHN S. CLARK IIROBERT W. BUTTSSOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP, LLCSOUTHPOINT GP, LP
Documents: 1

SEC Accession No.
0001362310-08-000908
Filing date: 2008-02-14
Accepted: 2008-02-14 12:21:42

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13G/A	c72466sc13gza.htm	85456	SCHEDULE 13G/A

		0001362310-08-000908.txt	87745	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 08611221
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628

Southpoint Capital Advisors LP (Filed by) (0001319998)
IRS No.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: | Film No.:

Business Address
237 PARK AVENUE
SUITE 900
NEW YORK NY 10017
212.692.6350

Mailing Address
237 PARK AVENUE
SUITE 900
NEW YORK NY 10017